(2026) Extended Data Fig
Lab Anim Res (2013) 29(1):1
When GM dysbiosis or intestinal barrier dysfunction occurs, bacteria and endotoxins enter the liver via the biliary tract and portal vein, activating hepatic cell surface receptors and releasing inflammatory factors, thereby damaging hepatocytes and ultimately leading to liver inflammation and fibrosis
Without these critical cofactors, the metabolic assembly line stalls, leading to a buildup of toxic metabolites that can trigger symptoms identical to severe histamine intolerance
doi: 10.1007/s00223-015-9993-5
The BPC-157 and TB-500 stack is best suited for: Athletes: Managing soft tissue injuries and wanting to accelerate return to training without compromising repair quality Post-surgical patients: Looking to improve tissue recovery quality and reduce scar formation Chronic tendinopathy patients: Who have not responded adequately to physical therapy alone Inflammation-driven conditions: Where systemic inflammatory signaling or gut permeability is part of the clinical picture The protocol is not appropriate for patients with active cancer or cancer history (growth factor upregulation is contraindicated), autoimmune disease where immune modulation carries additional risk, pregnancy or breastfeeding, or those with compromised liver or kidney function